Φορτώνει......
Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome
Rituximab (RTX) is a murine–human chimeric monoclonal antibody against CD20 that has been proven effective for preventing relapse in frequently-relapsing or steroid-dependent nephrotic syndrome (NS). Serum sickness, a type-3 hypersensitivity reaction resulting from injection of foreign proteins, has...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | CEN Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Singapore
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7148389/ https://ncbi.nlm.nih.gov/pubmed/31970629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-020-00449-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|